These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37872702)

  • 1. Insulin, but not adiponectin, is detectable in equine saliva using an automated, commercial assay.
    Barnabé MA; Elliott J; Harris PA; Menzies-Gow NJ
    Equine Vet J; 2024 Mar; 56(2):361-367. PubMed ID: 37872702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and application of immunoturbidimetric and enzyme-linked immunosorbent assays for the measurement of adiponectin concentration in ponies.
    Menzies-Gow NJ; Knowles EJ; Rogers I; Rendle DI
    Equine Vet J; 2019 Jan; 51(1):33-37. PubMed ID: 29679396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between total adiponectin concentrations and obesity in native-breed ponies in England.
    Barnabé MA; Elliott J; Harris PA; Menzies-Gow NJ
    Equine Vet J; 2024 Mar; 56(2):264-272. PubMed ID: 37800870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term induced hyperinsulinaemia and dexamethasone challenge do not affect circulating total adiponectin concentrations in insulin-sensitive ponies.
    Barnabé MA; Elliott J; Harris PA; Menzies-Gow NJ
    Equine Vet J; 2024 Mar; 56(2):332-341. PubMed ID: 37800859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA; Sillence MN; Reiche DB
    J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1, insulin-like growth factor-1, and adiponectin in insulin-dysregulated ponies: effects of feeding a high nonstructural carbohydrate diet and association with prospective laminitis.
    Meier AD; de Laat MA; Reiche DB; Sillence MN
    Domest Anim Endocrinol; 2020 Apr; 71():106397. PubMed ID: 31812879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of laminitis development in a cohort of nonlaminitic ponies.
    Knowles EJ; Elliott J; Harris PA; Chang YM; Menzies-Gow NJ
    Equine Vet J; 2023 Jan; 55(1):12-23. PubMed ID: 35263471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
    de Laat MA; Reiche DB; Sillence MN; McGree JM
    J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field treatment and management of endocrinopathic laminitis in horses and ponies.
    Walsh DM
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):379-90. PubMed ID: 20699182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to endocrinopathic laminitis in the field: Results of a survey of veterinary practitioners in North America.
    Rumfola E; Banse HE; Atkins M; McGowan CM; Ireland JL
    J Equine Vet Sci; 2022 Mar; 110():103856. PubMed ID: 34958881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of cellular and molecular mechanisms in endocrinopathic, sepsis-related and supporting limb equine laminitis.
    Elliott J; Bailey SR
    Equine Vet J; 2023 May; 55(3):350-375. PubMed ID: 36847165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.
    Menzies-Gow NJ; Harris PA; Elliott J
    Equine Vet J; 2017 May; 49(3):300-306. PubMed ID: 27363591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-2: A potential role in equine insulin dysregulation.
    de Laat MA; Fitzgerald DM; Sillence MN; Spence RJ
    Equine Vet J; 2018 Nov; 50(6):842-847. PubMed ID: 29502360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic Effects of Pioglitazone on High Molecular Weight Adiponectin Concentrations and Insulin Response After Oral Sugar in Equids.
    Legere RM; Taylor DR; Davis JL; Bello K; Parker C; Judd RL; Wooldridge AA
    J Equine Vet Sci; 2019 Nov; 82():102797. PubMed ID: 31732109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of endocrine disease on l-lactate concentrations in blood of ponies.
    Dunkel B; Knowles EJ; Chang YM; Menzies-Gow NJ
    J Vet Intern Med; 2021 May; 35(3):1582-1588. PubMed ID: 34043845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamellar events related to insulin-like growth factor-1 receptor signalling in two models relevant to endocrinopathic laminitis.
    Lane HE; Burns TA; Hegedus OC; Watts MR; Weber PS; Woltman KA; Geor RJ; McCutcheon LJ; Eades SC; Mathes LE; Belknap JK
    Equine Vet J; 2017 Sep; 49(5):643-654. PubMed ID: 28078757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profile distinguishes laminitis-susceptible and -resistant ponies before and after feeding a high sugar diet.
    Delarocque J; Reiche DB; Meier AD; Warnken T; Feige K; Sillence MN
    BMC Vet Res; 2021 Jan; 17(1):56. PubMed ID: 33509165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of salivary resistin, visfatin and adiponectin levels.
    Mamali I; Roupas ND; Armeni AK; Theodoropoulou A; Markou KB; Georgopoulos NA
    Peptides; 2012 Jan; 33(1):120-4. PubMed ID: 22108712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating research into practice: Adoption of endocrine diagnostic testing in cases of equine laminitis.
    Ireland JL; McGowan CM
    Vet J; 2021 Jun; 272():105656. PubMed ID: 33941328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in insulin response to oral sugar test in a cohort of horses throughout the year and evaluation of risk factors for insulin dysregulation.
    Karikoski NP; Box JR; Mykkänen AK; Kotiranta VV; Raekallio MR
    Equine Vet J; 2022 Sep; 54(5):905-913. PubMed ID: 34713928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.